Torpharm Ticlopidine Ad To Run In August JAMA; Educational Materials Cited

Apotex' U.S. subsidiary Torpharm will run an advertisement in the August issue of the Journal of the American Medical Association referencing its safety education program for the first generic version of ticlopidine (Roche's Ticlid). Torpharm's ticlopidine cleared FDA July 1 with a therapeutically equivalent "AB" rating.